A detailed history of Sheets Smith Wealth Management transactions in Immunity Bio, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 665,995 shares of IBRX stock, worth $2.28 Million. This represents 0.51% of its overall portfolio holdings.

Number of Shares
665,995
Previous 945,720 29.58%
Holding current value
$2.28 Million
Previous $5.08 Million 17.11%
% of portfolio
0.51%
Previous 0.57%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$4.82 - $9.15 $1.35 Million - $2.56 Million
-279,725 Reduced 29.58%
665,995 $4.21 Million
Q1 2024

May 08, 2024

BUY
$3.23 - $6.17 $2.42 Million - $4.62 Million
749,041 Added 380.84%
945,720 $5.08 Million
Q4 2023

Feb 06, 2024

SELL
$1.25 - $5.21 $96,500 - $402,212
-77,200 Reduced 28.19%
196,679 $987,000
Q3 2023

Oct 23, 2023

BUY
$1.29 - $3.1 $6,127 - $14,725
4,750 Added 1.76%
273,879 $462,000
Q2 2023

Aug 09, 2023

SELL
$1.53 - $6.41 $2.02 Million - $8.47 Million
-1,321,269 Reduced 83.08%
269,129 $748,000
Q1 2023

May 26, 2023

BUY
$1.35 - $4.78 $2.15 Million - $7.6 Million
1,590,396 Added 0.0%
1,590,398 $2.89 Million
Q1 2023

May 12, 2023

SELL
$1.35 - $4.78 $2.08 Million - $7.38 Million
-1,544,046 Reduced 100.0%
2 $0
Q4 2022

Mar 08, 2023

BUY
$4.35 - $6.77 $5.81 Million - $9.05 Million
1,336,122 Added 642.59%
1,544,048 $7.83 Million
Q2 2022

Jul 27, 2022

BUY
$2.68 - $6.14 $10,854 - $24,867
4,050 Added 1.99%
207,926 $773,000
Q1 2022

May 02, 2022

BUY
$5.05 - $7.53 $260,580 - $388,548
51,600 Added 33.89%
203,876 $1.14 Million
Q4 2021

Jan 20, 2022

BUY
$5.67 - $10.18 $172,101 - $308,993
30,353 Added 24.9%
152,276 $926,000
Q3 2021

Oct 15, 2021

BUY
$9.17 - $14.24 $309,670 - $480,884
33,770 Added 38.31%
121,923 $1.19 Million
Q2 2021

Aug 03, 2021

BUY
$13.41 - $22.4 $891,805 - $1.49 Million
66,503 Added 307.17%
88,153 $1.26 Million
Q1 2021

Apr 23, 2021

BUY
$12.83 - $42.25 $277,769 - $914,712
21,650 New
21,650 $514,000

Others Institutions Holding IBRX

About ImmunityBio, Inc.


  • Ticker IBRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 400,304,000
  • Market Cap $1.37B
  • Description
  • ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...
More about IBRX
Track This Portfolio

Track Sheets Smith Wealth Management Portfolio

Follow Sheets Smith Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.